Reported Adverse Effects In the available case series and observational literature, the most commonly reported adverse effects include: Injection-site redness or mild induration in approximately 8 to 12% of users Transient nausea, most often associated with oral formulations or higher injectable doses Lightheadedness in a small number of patients shortly after injection (under 2% of reported cases) Vivid dreams or mild sleep changes, reported anecdotally by a subset of users with no clear mechanistic explanation No published human case reports as of July 2025 document serious organ toxicity, malignancy, or endocrine disruption attributable to BPC-157
Other considerations Headache and dizziness may occur, particularly during initial treatment
It has a sequence of Gly-His-Lys (glycine, histidine, and lysine,) which readily binds with copper to form the copper tripeptide
Glutathione, known as the master antioxidant, helps neutralize free radicals, detoxify the liver, and lighten hyperpigmentation